Transaction · 0001178913-26-004715

Raday Gilead

Raday Gilead, COO, reported an open-market or private sale at RedHill Biopharma Ltd. involving 14310000.000000 shares for an estimated $1431.00. Reported holdings after the transaction were 176910000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCOO
RDHLRedHill Biopharma Ltd.
Filing timeOct 06
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded7.48%Shares sold ÷ (holdings after + shares sold). Estimated position before: 191,220,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$0.48
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

RDHL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RDHL since 2026-10-06Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001178913-26-004715
Ordinary Shares
Transaction date
Oct 01, 2026
Filed Oct 06, 2026, 11:00 AM · 5d delay
Shares
14.3M sh
$0.00 per share
Estimated value
-$1.43k
Computed from shares × price
Holdings after
176M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Operating Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reporting person sold 1,431 American Depository Shares ("ADS"), of RedHill Biopharma Ltd. (the "Issuer"), each ADS represents 10,000 ordinary shares, which have no par value effective August 7, 20…

  2. F2

    The price reported in Table 1 Column 4 is $0.465 per ADS, which would be equivalent to $0.0000465 per ordinary share.

  3. F3

    Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date.

Original filing · 0001178913-26-004715
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RDHL